6Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. Gastroenterol Hepatol, 2002, 17: 1098-1105.
7Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 575-594.
8Day CP. The potential role of gene in nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 673-691.
9Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin liver Dis, 2004, 8: 639-671.
10Feldstein A, Gores GJ. Steatohepatitis and apoptosis: therapeutic implications. Am J Gastroenterol, 2004, 99: 1718-1719.
6Fan Jiangao,Farrell CA2. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol, 2009,50 : 204-210.
7Pagano C, Soardo G, Pilon C,et al. Increased serum resis- tin in nonalcoholic fatty liver disease is related to liver disease severity and not toinsulin resistance[J]. J Clin En- docrinol Metab, 2006,91 (3) : 1081-1086.
8Lizardi-Cervera J, Chavez-Tapia NC, Perez-Bautista O, et al. Association among C-reactive protein, {attyliver dis- ease, and cardiovascular risk[J]. Dig Dis Sci, 2007,52 (9) : 2375-2379.
9Wong VW, Hui AY, Tsang SW, et al. Metabolic and adl- pokine profdeof Chinese patients with nonaleoholic fatty liver disease[J]. Cuf I Gastroenteml Hepal, 2006,4 (9) :1154-1161.
10Crespo J, Cayon A, Femandez-Gil P, et al. Gene expres- sion of tumor necroxis factor alpha and TNF- receptors, p55 and p75, in nonalcoholic steatohepatitis patients[J]. Hepatoloty, 2001,34(6) : 1158-1161.
